UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Diabetes care, 2017-01, Vol.40 (1), p.69-76

2017

Link zum Volltext

Verfügbarkeit prüfen

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Circulation (New York, N.Y.), 2014-10, Vol.130 (18), p.1579-1588

2014

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c

The American journal of medicine, 2016-03, Vol.129 (3), p.340.e1-340.e8

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy

The journal of histochemistry and cytochemistry, 2005-09, Vol.53 (9), p.1087-1097

2005

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database

BMJ open, 2022-12, Vol.12 (12), p.e064953-e064953

2022

Link zum Volltext

Verfügbarkeit prüfen

The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study

The American heart journal, 2011-11, Vol.162 (5), p.818-825.e6

2011

Link zum Volltext

Verfügbarkeit prüfen

MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport

Journal of the American Heart Association, 2021-07, Vol.10 (13), p.e014572-e014572

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin

Clinical therapeutics, 2016-12, Vol.38 (12), p.2578-2588

2016

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”

Circulation (New York, N.Y.), 2015-08, Vol.132 (6), p.e121-e122

2015

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations

Diabetes care, 2013-08, Vol.36 (8), p.S253-S258

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs

Diabetes care, 2011-05, Vol.34 Suppl 2 (5), p.S101-S106

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Diabetes care, 2021-06, Vol.44 (6), p.1433-1442

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin

Cardiovascular diabetology, 2017-09, Vol.16 (1), p.113-113, Article 113

2017

Link zum Volltext

Verfügbarkeit prüfen

Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin

Diabetes care, 2015-03, Vol.38 (3), p.376-383

2015

Link zum Volltext

Verfügbarkeit prüfen

Hemoptysis: Etiology, Evaluation, and Outcome in a Tertiary Referral Hospital

Chest, 1997-08, Vol.112 (2), p.440-444

1997

Link zum Volltext

Verfügbarkeit prüfen

Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

Current Diabetes Reports, 2015-11, Vol.15 (11), p.87-87, Article 87

2015

Link zum Volltext

Verfügbarkeit prüfen

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression

Diabetes care, 2003-12, Vol.26 (12), p.3288-3295

2003

Link zum Volltext

Verfügbarkeit prüfen

Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging

Transplantation, 2005-04, Vol.79 (7), p.768

2005

Link zum Volltext

Verfügbarkeit prüfen

Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma

The journal of clinical endocrinology and metabolism, 2000-09, Vol.85 (9), p.3222-3226

2000

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial

Diabetes care, 2015-06, Vol.38 (6), p.1145-1153

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes

Diabetes care, 2015-11, Vol.38 (11), p.2009-2017

2015

Link zum Volltext

Verfügbarkeit prüfen

Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects

Diabetes, obesity & metabolism, 2008-06, Vol.10 (6), p.506-513

2008

Link zum Volltext

Verfügbarkeit prüfen

Histopathological Study of Intrahepatic Islets Transplanted in the Nonhuman Primate Model Using Edmonton Protocol Immunosuppression

The journal of clinical endocrinology and metabolism, 2002-12, Vol.87 (12), p.5424-5429

2002

Link zum Volltext

Verfügbarkeit prüfen

Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapy

Endocrine practice, 2014-11, Vol.20 (11), p.1187-1197

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus

Diabetes/metabolism research and reviews, 2014-10, Vol.30 (7), p.556-569

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(145)
Buchkapitel
(1)

Sprache

Englisch
(146)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(99)
Science & Technology
(99)
Humans
(78)
Male
(50)
Female
(49)
Endocrinology & Metabolism
(44)
Middle Aged
(40)
Biological And Medical Sciences
(38)
Medical Sciences
(37)
Diabetes
(33)
Diabetes Mellitus, Type 2 - Drug Therapy
(31)
Adult
(28)
Aged
(26)
Adamantane - Analogs & Derivatives
(25)
Clinical Trials
(18)
Double-Blind Method
(18)
Dipeptides - Adverse Effects
(16)
Treatment Outcome
(16)
Adamantane - Adverse Effects
(15)
Adamantane - Therapeutic Use
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c

Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy

Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database

The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study

MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport

Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin

Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations

Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin

Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin

Hemoptysis: Etiology, Evaluation, and Outcome in a Tertiary Referral Hospital

Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression

Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging

Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes

Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects

Histopathological Study of Intrahepatic Islets Transplanted in the Nonhuman Primate Model Using Edmonton Protocol Immunosuppression

Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapy

Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus

Suchergebnisse filtern